Key result
Deep learning CV risk models require accuracy, explainability, and failure-mode insights for clinical utility.
Why the study?
Deep learning models for cardiovascular risk stratification are challenging to evaluate beyond statistical measures, limiting insight into their clinical utility.
Deep learning models for cardiovascular risk stratification require not only accuracy but also explainability and insight into potential inaccuracies to be clinically useful.
Answers are grounded in this paper and cite their sources.
Proposed DL risk model evaluation framework highlights clinical utility gaps; leaves open prospective validation before cardiovascular adoption.
Purpose of review Although deep learning represents an exciting platform for the development of risk stratification models, it is challenging to evaluate these models beyond simple statistical measures of success, which do not always provide insight into a model’s clinical utility. Here we propose a framework for evaluating deep learning models and discuss a number of interesting applications in light of these rubrics. Recent findings Data scientists and clinicians alike have applied a variety of deep learning techniques to both medical images and structured electronic medical record data. In many cases, these methods have resulted in risk stratification models that have improved discriminatory ability relative to more straightforward methods. Nevertheless, in many instances, it remains unclear how useful the resulting models are to practicing clinicians. Summary To be useful, deep learning models for cardiovascular risk stratification must not only be accurate but they must also provide insight into when they are likely to yield inaccurate results and be explainable in the sense that health care providers can understand why the model arrives at a particular result. These additional criteria help to ensure that the model can be faithfully applied to the demographic for which it is most accurate.
No takes yet. Share an insight, caveat, or question.
Schlesinger et al. (2020) conducted a review in Cardiovascular disease. Deep learning models was evaluated. Deep learning models for cardiovascular risk stratification must be accurate, explainable, and provide insight into potential failure modes to be clinically useful.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: